Surya Pharmaceutical Ltd


BSE: 532516 | NSE: SURYAPHARM | ISIN: INE249G01020 
Market Cap: [Rs.Cr.] 22 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Quarterly Results

ParticularsDec-12
(Rs.Cr) 
Sep-12
(Rs.Cr) 
Jun-12
(Rs.Cr) 
Gross Sales 101531
Other Income  000
Total Income 101532
Total Expenditure  193454
PBIDT -9-19-22
Interest  595057
PBDT -68-69-79
Depreciation 1099
Tax 000
Deferred Tax 000
Reported Profit After Tax -78-78-88
Extra-ordinary Items  000
Adjusted Profit After Extra-ordinary item -78-78-88
    
EPS (Unit Curr.) -3.8-3.8-4.3
EPS (Adj) (Unit Curr.) -3.8-3.8-4.3
Calculated EPS (Unit Curr.) 0.00.00.0
Calculated EPS (Adj) (Unit Curr.) 0.00.00.0
Calculated EPS (Ann.) (Unit Curr.) 0.00.00.0
Calculated EPS (Adj) (Ann.) (Unit Curr.) 0.00.00.0
Book Value (Unit Curr.) 0.00.00.0
Dividend (%) 0.00.00.0
Equity 202020
Reserve & Surplus 0.00.00.0
Face Value 1.01.01.0
    
Non-Promoter Holding Shares 159,713,656159,713,656142,204,998
Non-Promoter Holding (%) 78.7778.7770.14
    
PBIDTM(%) -88.32-122.16-69.94
PBDTM(%) -676.05-452.46-251.44
PATM(%) -777.84-511.48-281.08
 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 104,238.32 72.41 12.86 27.45 26.1 27.0 0.01
Dr Reddy's Labs 34,830.93 27.52 4.58 18.79 14.3 16.6 0.25
Cipla 33,320.35 21.76 4.42 14.11 15.9 19.8 0.03
Ranbaxy Labs. 16,634.18 0.00 8.66 72.87 0.0 0.0 2.38
Cadila Health. 16,123.28 39.08 6.32 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,495.48 40.14 6.14 23.94 12.7 11.7 0.39
Wockhardt 14,412.51 85.85 119.79 12.82 237.0 30.3 2.09
Piramal Enterp. 9,590.33 0.00 0.91 23.66 0.8 2.1 0.07
Ipca Labs. 7,297.52 21.94 5.78 10.09 24.2 23.7 0.49
Torrent Pharma. 6,005.90 11.23 4.60 11.66 29.6 25.5 0.48
Biocon 5,512.00 19.22 2.50 12.20 12.6 13.6 0.08
Strides Arcolab 5,229.76 35.65 3.81 46.94 7.3 8.9 0.56
Aurobindo Pharma 5,081.44 12.08 2.04 22.89 10.7 8.8 1.01
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,260.12 14.36 4.92 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Alka Goyal , Executive Director 

Rajiv Goyal , Chairman & Managing Director 

D P Singhal , Independent Director 

S K Yadav , Additional Director 


Company Head Office / Quarters:
1596 1st Floor,
Bhagirath Palace,
Delhi,
Delhi-110006
Phone :
Fax :
E-mail :
sales@suryapharma.com
rajivg@suryapharma.com
Web : http://www.suryapharma.com
Registrars:
Big Share Services Pvt Ltd
E-2/3 Saki Vihar Rd
Ansa Indl Estate
Saki Naka Andheri-E
Mumbai - 400 072

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Opening : India Finsec
Economic Events
list Balance (YTD) (New Zealand dollars)
list Cap Goods Orders Nondef Ex Air
Results
list Britannia Inds. | Crompton Greaves | M R P L | Jet Airways